Pharmacyclics Inc (PCYC) 254.22 $PCYC Jim Crame
Post# of 64074
Jim Cramer's 'Mad Money' Recap: Why Aren't Well-Run Companies Getting Respect?
at The Street - 1 hr 39 mins ago
Cramer says what seems overvalued on paper today might surprise you and be in a whole new category tomorrow.
BID: 41.73 (-0.02), TSLA: 200.63 (-1.80), GWRE: 53.04 (-0.33), ZIOP: 13.81 (+0.47), GE: 25.82 (+0.16), LMT: 199.10 (+0.13), PCYC: 254.22 (+23.74), BX: 39.14 (+0.53), BMRN: 113.50 (+3.71), UTX: 120.79 (-0.25), HZO: 25.43 (+0.35), XOM: 86.74 (-0.44), CZR: 10.16 (-0.20), SBUX: 93.63 (+0.57), ETP: 58.05 (-0.20), SSYS: 64.31 (+2.44), RCPT: 141.19 (+13.19), COST: 151.17 (+4.00), ABBV: 56.86 (-3.41), TRAK: 40.72 (+0.64), ROL: 34.00 (+0.09), OA: 67.75 (-0.45), MOV: 24.45 (-0.19), MBLY: 37.02 (+2.21), CSCO: 29.30 (-0.03), URI: 92.06 (-0.28), CTRL: 12.42 (-0.12), AMZN: 387.83 (+5.11), GPRO: 41.08 (-1.93), KR: 74.31 (+4.66), WFC: 54.84 (+0.02), NXPI: 98.67 (-0.80), BMY: 66.05 (+0.38), BA: 154.47 (+0.12), HPQ: 34.00 (-0.19), DRI: 64.21 (+1.32), ISIS: 71.76 (+1.60), MCD: 99.11 (-1.14), CVX: 104.73 (-0.43), BABA: 86.10 (+0.61)
Irish Highlanders: Drug Stocks Mallinckrodt, Horizon Pharma Rally
at Investor's Business Daily - Thu Mar 05, 5:32PM CST
Drugmakers seized market headlines Thursday when Pharmacyclics (PCYC) spiked 10% on word that it would be acquired by AbbVie (ABBV) in a $21 billion cash and stock deal. The news sent AbbVie down 5% in heavy trade, but also launched a mild rally...
MNK: 121.70 (+5.51), PCYC: 254.22 (+23.74), TARO: 152.07 (+0.24), HZNP: 20.84 (-0.33), ABBV: 56.86 (-3.41), ICLR: 67.84 (+0.12)
Nasdaq stocks posting largest volume increases
AP - Thu Mar 05, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
SFST: 16.60 (-0.28), PCYC: 254.22 (+23.74), KYTH: 50.00 (+10.10), HWBK: 13.92 (+0.03), EML: 19.54 (-0.18), CNDO: 3.37 (+0.14), XPLR: 6.08 (-0.14), BOBE: 47.76 (+1.40), NWFL: 28.68 (+0.02), DJCO: 201.70 (+1.49), TSRI: 4.87 (-0.20), HTWO: 10.14 (-0.15)
Most active Nasdaq-traded stocks
AP - Thu Mar 05, 5:04PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
MU: 29.28 (+0.02), PCYC: 254.22 (+23.74), FB: 81.21 (+0.32), INTC: 33.73 (-0.39), OREX: 8.01 (-0.48), FOX: 34.03 (-0.04), GERN: 3.78 (+0.97), FOXA: 34.87 (-0.10), MSFT: 43.11 (+0.05), ZNGA: 2.41 (+0.02), AAPL: 126.41 (-2.13), CSCO: 29.30 (-0.03)
AbbVie Stock Slides On Pricey Pharmacyclics Deal
at Investor's Business Daily - Thu Mar 05, 3:56PM CST
Big pharma AbbVie's $21 billion deal to acquire hot biotech Pharmacyclics was met with widespread skepticism by AbbVie investors Thursday, sending AbbVie's stock falling 5.7% Thursday. AbbVie (ABBV) announced the cash-and-stock acquisition late...
JNJ: 102.52 (+0.87), PCYC: 254.22 (+23.74), PFE: 34.47 (-0.17), AMGN: 159.60 (+0.41), ABBV: 56.86 (-3.41), NVS: 98.95 (-0.09)
Stocks Notch Small Gains Ahead of February Jobs Report
at The Street - Thu Mar 05, 3:43PM CST
Stocks manage to close with gains on Thursday, but just barely ahead of the February jobs report on Friday
PCYC: 254.22 (+23.74), C: 53.56 (-0.11), WYNN: 139.00 (+0.18), BAC: 16.00 (+0.16), LVS: 56.36 (-0.64), JNJ: 102.52 (+0.87), GS: 190.08 (+0.41), JPM: 62.00 (-0.13), MPEL: 24.17 (-0.77), COST: 151.17 (+4.00), ABBV: 56.86 (-3.41), AAPL: 126.41 (-2.13)
AbbVie and Costco are big market movers
AP - Thu Mar 05, 3:35PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
AMBA: 64.39 (-3.10), PCYC: 254.22 (+23.74), COST: 151.17 (+4.00), BOBE: 47.76 (+1.40), PEIX: 11.75 (+2.42), SMTC: 26.30 (-2.99), SWHC: 14.40 (+0.06)
Stocks Rise From Pullback; Pharmacyclics Jumps On Buyout News
at Investor's Business Daily - Thu Mar 05, 3:24PM CST
Stocks rose for the first time in three sessions Thursday, amid mixed economic data and news that the European Central Bank will start its quantitative easing soon. The Nasdaq rose 0.3%, while the Dow Jones industrial average edged up 0.2% and the...
SPLS: 16.50 (-0.09), MNK: 121.70 (+5.51), PCYC: 254.22 (+23.74), MIDD: 104.46 (+3.15), ABBV: 56.86 (-3.41), FL: 57.03 (-0.46), BIG: 47.82 (+0.41)
The Under-the-Radar Reason Why Puma Biotechnology Inc. Rocketed 17% Higher
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 05, 2:15PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Puma Biotechnology , a clinical-stage...
PCYC: 254.22 (+23.74), ABBV: 56.86 (-3.41), PBYI: 243.17 (+36.21)
Stocks' Gains Are Limited in Lead-Up to February Jobs Report
at The Street - Thu Mar 05, 2:10PM CST
Stocks regain positive momentum by mid-afternoon. Weaker-than-expected domestic data and the materials sector kept gains limited.
JOY: 39.94 (-2.19), XLB: 51.15 (-0.22), PCYC: 254.22 (+23.74), KR: 74.31 (+4.66), C: 53.56 (-0.11), WYNN: 139.00 (+0.18), BAC: 16.00 (+0.16), LVS: 56.36 (-0.64), TWX: 83.26 (+0.18), GS: 190.08 (+0.41), CPE: 7.16 (-0.29), JPM: 62.00 (-0.13), ANF: 20.21 (-0.06), MPEL: 24.17 (-0.77), COST: 151.17 (+4.00), ABBV: 56.86 (-3.41), AAPL: 126.41 (-2.13)
Stocks Turn Positive; Embraer Falls On Weak Earnings
at Investor's Business Daily - Thu Mar 05, 2:00PM CST
Stocks were modestly higher with an hour to go in Thursday's session as investors weighed mixed U.S. economic data and new European Central Bank stimulus. The Nasdaq was up 0.3%, the Dow Jones industrial average climbed 0.2% and the S&P 500 edged up...
MNK: 121.70 (+5.51), JOY: 39.94 (-2.19), AMBA: 64.39 (-3.10), PCYC: 254.22 (+23.74), ERJ: 33.33 (-1.57), QLYS: 49.74 (+2.26), ABBV: 56.86 (-3.41)
Stocks Nearly Flat In Afternoon; Qualys Climbs To New High
at Investor's Business Daily - Thu Mar 05, 12:30PM CST
Stocks were flat Thursday afternoon as investors weighed mixed U.S. economic data and new stimulus efforts by the European Central Bank. The Nasdaq and the Dow Jones industrial average were both flat, while the S&P 500 slipped 0.1%. All three indexes...
JOY: 39.94 (-2.19), PCYC: 254.22 (+23.74), SFM: 35.19 (+0.46), QLYS: 49.74 (+2.26), ABBV: 56.86 (-3.41)
Nasdaq stocks posting largest percentage increases
AP - Thu Mar 05, 12:29PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
HYGS: 14.78 (+1.02), DVAX: 21.56 (+0.25), PCYC: 254.22 (+23.74), HYG.TO: 18.50 (+1.45), ATRA: 28.75 (+2.20), CECO: 6.00 (unch), OREX: 8.01 (-0.48), EVOK: 6.03 (+0.61), PRQR: 21.37 (+1.88), FCSC: 5.94 (+0.29), KYTH: 50.00 (+10.10), ATTU: 10.43 (+1.05), MRTX: 26.65 (+2.25), PEIX: 11.75 (+2.42)
AbbVie to buy leukemia drugmaker Pharmacyclics for $21B
By TOM MURPHY - AP - Thu Mar 05, 12:17PM CST
AbbVie will spend about $21 billion to buy fellow drugmaker Pharmacyclics and add another major revenue producer to a portfolio that already includes the world's top-selling drug.
PCYC: 254.22 (+23.74), AMGN: 159.60 (+0.41)
Geron gets boost from AbbVie-Pharmacyclics deal
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 11:15AM CST
JNJ: 102.52 (+0.87), PCYC: 254.22 (+23.74), GERN: 3.78 (+0.97), ABBV: 56.86 (-3.41)
Stocks Higher At Noon; Costco, Middleby Rebound
at Investor's Business Daily - Thu Mar 05, 11:03AM CST
Stocks were modestly higher at midday Thursday following a large acquisition in the health care sector and bullish comments by the European Central Bank. The Nasdaq was up 0.4%, the Dow Jones industrial average gained 0.3% and the S&P 500 climbed...
PCYC: 254.22 (+23.74), MIDD: 104.46 (+3.15), ABBV: 56.86 (-3.41), BITA: 73.46 (+5.22)
Mallinckrodt Stock Hits High On Ikaria Buyout
at Investor's Business Daily - Thu Mar 05, 10:52AM CST
Specialty drugmaker Mallinckrodt (MNK) announced a $2.3 billion deal Thursday to acquire privately held Ikaria, which was greeted with enthusiasm on the stock market. Ikaria makes INOmax, an inhaled nitric oxide used to treat newborns with...
MNK: 121.70 (+5.51), PCYC: 254.22 (+23.74), ABBV: 56.86 (-3.41)
How These Healthcare Megadeals Helped Send the Market Higher
Dan Caplinger, The Motley Fool - Motley Fool - Thu Mar 05, 10:03AM CST
AbbVie made a big purchase overnight. Source: AbbVie. As the stock market has climbed, many investors have become increasingly concerned about whether its gains are sustainable. One key signal that can determine whether stocks are overpriced comes...
MNK: 121.70 (+5.51), PCYC: 254.22 (+23.74), ABBV: 56.86 (-3.41)
Pharmacyclics (PCYC) Stock Spikes Today Following $21 Billion AbbVie Merger Deal
at The Street - Thu Mar 05, 9:56AM CST
Pharmacyclics (PCYC) shares are up double digits after the company announced that it was purchased by AbbVie (ABBV) for $21 billion.
PCYC: 254.22 (+23.74)